Postoperative analgesia
Conditions
Interventions
experimental group 1:30ml 0.375% ropivacaine was injected into the iliac fascia space under ultrasound guidance
experimental group 2:Under ultrasound, 20ml 0.375% ropivacaine was injected around the hip joint capsule, and 10ml 0.375% ropivacaine was injected around the femoral lateral cutaneous nerve
Sponsors
The Third Affiliated Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years; gender is not limited; 2. ASA I-II level; 3. Elective hip arthroscopy is required; 4. Voluntarily participated and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Preoperative combined peripheral nerve injury or disease; 2. Long-term oral painkillers for chronic pain; 3. Severe compound trauma; 4. Women during lactation and pregnancy; 5. A history of steroid use within two weeks of the study; 6. There are contraindications for regional block; 7. The patient has a history of allergy to the study drug; 8. Diabetic patients; 9. The wound is infected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle strength grade;Pain score;The night of surgery and the first postoperative night sleep quality;Patient satisfaction;Surgeon satisfaction;15-item Recovery Quality Rating Scale;Pain intensity and opioid consumption (PIOC) scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Block time of sensory and motor nerves; | — |
Countries
China
Contacts
Public ContactWang Qiujun
The Third Hospital of Hebei Medical University
Outcome results
None listed